Difference in response of NK cell activity in newborns and adults to IL- 2, IL-12 and IL-15

Microbiology and Immunology

Volumn 43, Issue 2, 1999, Pages 161-166

  Hoshina, Takayuki ^a   Kida, Kazunori ^a   Ito, Masahiro ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IL 12; IL 15; IL 2; NK activity

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2;

ADULT; ARTICLE; CELL KILLING; CELL SUBPOPULATION; CYTOMEGALOVIRUS; FIBROBLAST; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; NEWBORN; UMBILICAL CORD BLOOD;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0033024955     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb02387.x     Document Type: Article

References (31)

1. Bandyopadhyay, S., Miller, D.S., Matsumoto-Kobayashi, M., Clark, S.C., and Starr, S.E. 1987. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts. Clin. Exp. Immunol. 67: 372-382.
2. Bandyopadhyay, S., Perussia, B., Trinchieri, G., Miller, D.S., and Starr, S.E. 1986. Requirement for HLA-DR + accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J. Exp. Med. 164: 180-195.
3. Borysiewicz, L.K., Rodgers, B., Morris, S., Graham, S., and Sissons, J.G. 1985. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterisation of effector cells. J. Immunol. 134: 2695-2701.
4. Carson, W.E., Giri, J.G., Lindemann, M.J., Linett, M.L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., and Caligiuri, M.A. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180: 1395-1403.
5. Chehimi, J., Valiante, N.M., D'Andrea, A., Rengaraju, M., Rosado, Z., Kobayashi, M., Perussia, B., Wolf, S.F., Starr, S.E., and Trinchieri, G. 1993. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23: 1826-1830.
6. 0 subunits. J. Immunol. 156: 1339-1348.
7. Fitzgerald, P.A., Evans, R., Kirkpatrick, D., and Lopez, C. 1983. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-I-infected fibroblasts and K562 erythroleukemia targets. J. Immunol. 130: 1663-1667.
8. Gaddy, J., and Broxmeyer, H.E. 1997. Cord blood CD16 + 56 - cells with low lytic activity are possible precursors of mature natural killer cells. Cell. Immunol. 180: 132-142.
9. Gaddy, J., Risdon, G., and Broxmeyer, H.E. 1995. Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. J. Interferon Cytokine Res. 15: 527-536.
10. Gamero, A.M., Ussery, D., Reintgen, D.S., Puleo, C.A., and Djeu, J.Y. 1995. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res. 55: 4988-4994.
11. Giri, J.G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L.S., Cosman, D., and Anderson, D. 1994. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13: 2822-2830.
12. Harris, M.C., and Polin, R.A. 1983. Neonatal septicemia. Pediatr. Clin. North Am. 30: 243-258.
13. Hassan, J., and Reen, D.J. 1996. Reduced primary antigen-specific T-cell precursor frequencies in neonates is associated with deficient interleukin-2 production. Immunology 87: 604-608.
14. Hayward, A.R., Herberger, M.J., Groothuis, J., and Levin, M.R. 1984. Specific immunity aller congenital or neonatal infection with cytomegalovirus or herpes simplex virus. J. Immunol. 133: 2469-2473.
15. Henney, C.S., Kuribayashi, K., Kern, D.E., and Gillis, S. 1981. Interleukin-2 augments natural killer cell activity. Nature 291: 335-338.
16. Herberman, R.B. 1981. Natural killer (NK) cells and their possible roles in resistance against disease. Clin. Immunol. Rev. 1: 1-65.
17. Ito, M., Watanabe, M., Kamiya, H., and Sakurai, M. 1996. Non-radioactive assay of natural killer cell-mediated cytotoxicity against cytomegalovirus-infected fibroblasts by DNA fragmentation ELISA. J. Virol. Methods 56: 77-84.
18. Kobayashi, M., Fitz, L., Ryan, M., Heweick, R.M., Clark, S.C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-845.
19. Kohl, S., West, M.S., and Loo, L.S. 1988. Defects in interleukin-2 stimulation of neonatal natural killer cytotoxicity to herpes simplex virus-infected cells. J. Pediatr. 112: 976-981.
20. Lanier, L.L., Benike, C.J., Phillips, J.H., and Engleman, E.G. 1985. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte sub-populations expressing the Leu-7 and Leu-11 antigens. J. Immunol. 134: 794-801.
21. Lau, A.S., Sigaroudinia, M., Yeung, M.C., and Kohl, S. 1996. Interleukin-12 induces interteron-γ expression and natural killer cytotoxicity in cord blood mononuclear cells. Pediatr. Res. 39: 150-155.
22. Lee, S.M., Suen, Y. Chang, L., Bruner, V., Qian, J., Indes, J., Knoppel, E., van de Ven, C., and Cairo, M.S. 1996. Decreased interleukin-12 (1L-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-γ, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 88: 945-954.
23. Leibson, P.J., Hunter-Laszlo, M., Douvas, G.S., and Hayward, A.R. 1986. Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines. J. Clin. Immunol. 6: 216-224.
24. Miyasaka, N., Darnell, B., Baron, S., and Talal, N. 1984. Interleukin 2 enhances natural killing of normal lymphocytes. Cell. Immunol. 84: 154-162.
25. Munger, W., DeJoy, S.Q., Jeyaseelan, R., Sr., Torley, L.W., Grabstein, K.H., Eisenmann, J., Paxton, R., Cox, T., Wick, M.M., and Kerwar, S.S. 1995. Studies evaluating the anti-tumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell. Immunol. 165: 289-293.
26. Nguyen, Q.H., Roberts, R.L., Ank, B.J., Lin, S.J., Lau, C.K., and Stiehm, E.R. 1998. Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2)and IL-12. Clin. Diagn. Lab. Immunol. 5: 98-104.
27. Pass, R.F., Stagno, S., Myers, G.J., and Alford, C.A. 1980. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 66: 758-762.
28. Qian, J.X., Lee, S.M., Suen, Y., Knoppel, E., van de Ven, C., and Cairo, M.S. 1997. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 90: 3106-3117.
29. Svedersky, L.P., Shepard, H.M., Spencer, S.A., Shalaby, M.R., and Palladino, M.A. 1984. Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2. J. Immunol. 133: 714-718.
30. Trinchieri, G., and Perussia, B. 1984. Human natural killer cells: biologic and pathologic aspects. Lab. Invest. 50: 489-513.
31. Watson, W., Oen, K., Ramdahin, R., and Harman, C. 1991. Immunoglobulin and cytokine production by neonatal lymphocytes. Clin. Exp. Immunol. 83: 169-174.